Tablets containing sulfadiazine, a short-acting sulfonamide antibiotic targeting folate synthesis in bacteria. Generic production for distribution to toxoplasmosis management programs, burn units, and hospital pharmacies procuring for immunocompromised patients and nocardiosis cases in clinical practice.